Objective. To examine gender differences in the characteristics and prevalence of various categories of glucose tolerance in a population study in Mauritius.
Introduction
The most recent reports from the American Diabetes Association (ADA) 1 and World Health Organization (WHO) consultation 2 on diagnosis and diagnostic criteria for diabetes include categories of impaired glucose metabolism. These categories identify persons with elevated fasting and/or post-load blood glucose concentrations which have been shown to be associated with high risk of progression to diabetes [3] [4] [5] [6] as well as risk of future cardiovascular disease [6] [7] [8] [9] [10] .
It is already apparent that there are significant differences between impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), both in their respective prevalence within a population, and in the classification of individuals 5, 11 . Furthermore, it also appears that there might be some sex differences, with IGT being more common in women and IFG more common in men. We set out to explore this sex difference further, as it may have important implications both for the understanding of the pathogenesis of abnormal glucose metabolism and for the methods of screening men and women for this condition. The implications for screening are highly pertinent, especially since the ADA proposes the use of fasting plasma glucose (FPG) alone, which cannot identify IGT.
Research design and methods

Background and subjects
Data collected in a population-based study conducted in Mauritius in 1998 were used to determine the prevalence of impaired glucose metabolism in men and women and to These findings were the same when either adjusted or unadjusted glucose values were used (data not shown).
Statistical analyses
Comparisons of the characteristics of non-diabetic men and women within different categories of glucose tolerance are shown in Table 2 . With the exception of females being slightly older than males among those with IFG, there were no significant differences between the sexes for age or prevalence of hypertension within the four non- Men had significantly higher mean FPG (p<0.001) and significantly lower 2hPG (p<0.001) than women. These differences remained highly significant (p<0.01) even after adjusting for all other variables in Table 2 . When only FPG values were considered irrespective of diabetes status based on the 2hPG, the proportion with a FPG in the range 6.1 to 6.9 mmol/l was 13.4% in men and 9.7% in women (p<0.0001). Also, when only 2hPG was considered irrespective of diabetes status based on the FPG, the proportion with a value between 7.8 and 11.1 mmol/l was 16.1% in men and 21.0% in women (p<0.0001).
Discussion
Data from this population-based survey show distinct sex differences in the prevalence of IFG and IGT, with IGT being more common in women and IFG more common in men. Other recent epidemiological studies [17] [18] [19] [20] [21] [22] [23] [24] have also reported similar sex differences in the prevalence of IFG and IGT, and the majority of IGT studies reviewed by the WHO showed that IGT was more common in men than women 25 . Furthermore, we have now described a difference in the relationship between FPG and 2hPG in men and women that may contribute to this phenomenon.
While there may be some overlap between IFG and IGT, it is now quite apparent that they identify different sub-populations 5, 11, 26, 27 . This is understandable in the context that IFG reflects the basal fasting state while IGT signals postprandial abnormalities.
Even though it is now clear that IFG and IGT encompass different sub-populations, using glucose measurements alone it is difficult to differentiate between the precise underlying abnormalities of insulin resistance and ß-cell dysfunction which lead to the conditions 28, 29 . Therefore, although the new category of IFG may broaden the description of intermediate abnormal states in glucose metabolism, it should be seen as complementary to IGT rather than its replacement. Screening programs aimed at identifying people at risk of developing diabetes that rely solely on the FPG, chance missing a considerable proportion of the at-risk population, and if our observations are further confirmed, may result in a sex-biased selection of individuals.
Previous studies looking at insulin resistance and beta cell function in IFG and IGT have produced conflicting results. Data from the Pima Indian studies suggest that IFG and IGT are associated with similar abnormalities of insulin action, and that IFG is also associated with reduced insulin secretory capacity 30, 31 . This finding was supported in a recent paper from the United Kingdom 28 . However, the Botnia study reported the opposite, with the IFG group displaying insulin resistance, whereas subjects with IGT had impaired secretory capacity 19 . Our data are in keeping with the findings from the Pima and UK populations, and show that both categories are insulin resistant, and that beta cell function is reduced in those with IFG, but not those with IGT. In Mauritius we found that men have lower levels of beta cell function and higher rates of IFG than women, and women have lower insulin sensitivity than men and higher rates of IGT.
The 2hPG associated with any given FPG is higher in women than men in this population. This remained true even after adjusting for a range of factors, including body weight. Thus, these male-female differences are not simply a consequence of However, in addition to the apparent difference in the relationship between FPG and 2hPG by sex, we found significant differences in the proportion of men and women with a FPG in the range 6.1 to 6.9 mmol/l or a 2hPG between 7.8 and 11.1 mmol/l regardless of the other respective glucose value. Adjusting for obesity using BMI or WHR did not explain the sex differences in either FPG or 2hPG. The importance of these sex 
